| GTO ID | GTC0619 |
| Trial ID |
2004-003934-32
|
| Disease |
Familial Hypercholesterolemia
|
| Altered gene | APOB |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | ISIS 301012|mipomersen sodium|Kynamro |
| Location approved | US, Mexico, Argentina, South Korea |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | A Phase II, Randomized, Double Blind, Placebo-Controlled Study to assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Varying Loading and Maintenance Dosing Regimens of ISIS 301012 Administered to Hypercholesterolemic Subjects. |
| Year | 2005 |
| Country | Germany |
| Company sponsor | Isis Pharmaceuticals Inc. |